Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

NCT00304031 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1173

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: Concurrent temozolomide
RADIATION: Concurrent radiation therapy
DRUG: 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle
DRUG: 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]